Home Self-Collection by Mail to Test for Human Papillomavirus and Sexually Transmitted Infections
- PMID: 30399091
- PMCID: PMC6249061
- DOI: 10.1097/AOG.0000000000002964
Home Self-Collection by Mail to Test for Human Papillomavirus and Sexually Transmitted Infections
Abstract
Objective: To evaluate the validity and acceptability of at-home self-collection to test for high-risk human papillomavirus (HPV) and sexually transmitted infections among women overdue for cervical cancer screening by national guidelines.
Methods: Low-income, infrequently screened women were recruited from the general population in North Carolina to participate in an observational study. Participants provided two self-collected cervicovaginal samples (one at home and one in the clinic) and a clinician-collected cervical sample. Samples were tested for high-risk HPV, Chlamydia trachomatis, Neisseria gonorrhoeae, Trichomonas vaginalis, and Mycoplasma genitalium. Cervical samples were also tested by liquid-based cytology.
Results: Overall, 193 women had conclusive high-risk HPV results for all three samples and cytology results. Prevalence of high-risk HPV within self-home samples (12.4%) was not different from that within clinician samples (11.4%; P=.79) and from that within self clinic samples (15.5%; P=.21). Positivity for high-risk HPV in all sample types increased with increasing grades of cervical abnormality (P<.001). Self-home samples detected high-risk HPV in all identified cases of high-grade squamous intraepithelial lesions and of cervical intraepithelial neoplasia 2 or worse. Detection was comparable across sample types for T vaginalis (range 10.2-10.8%), M genitalium (3.3-5.5%), C trachomatis (1.1-2.1%), and N gonorrhoeae (0-0.5%). Kappa values between sample types ranged from 0.56 to 0.66 for high-risk HPV, 0.86-0.91 for T vaginalis, and 0.65-0.83 for M genitalium. Most participants reported no difficulty understanding self-collection instructions (93.6%) and were willing to use self-collection in the future (96.3%).
Conclusion: Mail-based, at-home self-collection for high-risk HPV and sexually transmitted infection detection was valid and well accepted among infrequently screened women in our study. These findings support the future use of high-risk HPV self-collection to increase cervical cancer screening rates among higher risk women in the United States.
Conflict of interest statement
The other authors did not report any potential conflicts of interest.
Figures
Similar articles
-
Prospective Evaluation of Cervicovaginal Self- and Cervical Physician Collection for the Detection of Chlamydia trachomatis, Neisseria gonorrhoeae, Trichomonas vaginalis, and Mycoplasma genitalium Infections.Sex Transm Dis. 2018 Jul;45(7):488-493. doi: 10.1097/OLQ.0000000000000778. Sex Transm Dis. 2018. PMID: 29465667 Free PMC article.
-
Identifying a consensus sample type to test for Chlamydia trachomatis, Neisseria gonorrhoeae, Mycoplasma genitalium, Trichomonas vaginalis and human papillomavirus.Clin Microbiol Infect. 2018 Dec;24(12):1328-1332. doi: 10.1016/j.cmi.2018.03.013. Epub 2018 Mar 17. Clin Microbiol Infect. 2018. PMID: 29559392
-
Sexually transmitted infections among HIV-infected and HIV-uninfected women in the Tapajós region, Amazon, Brazil: Self-collected vs. clinician-collected samples.PLoS One. 2019 Apr 23;14(4):e0215001. doi: 10.1371/journal.pone.0215001. eCollection 2019. PLoS One. 2019. PMID: 31013277 Free PMC article. Clinical Trial.
-
Accuracy of human papillomavirus testing on self-collected versus clinician-collected samples: a meta-analysis.Lancet Oncol. 2014 Feb;15(2):172-83. doi: 10.1016/S1470-2045(13)70570-9. Epub 2014 Jan 14. Lancet Oncol. 2014. PMID: 24433684 Review.
-
High-risk HPV testing on self-sampled versus clinician-collected specimens: a review on the clinical accuracy and impact on population attendance in cervical cancer screening.Int J Cancer. 2013 May 15;132(10):2223-36. doi: 10.1002/ijc.27790. Epub 2012 Sep 14. Int J Cancer. 2013. PMID: 22907569 Review.
Cited by
-
HPV self-collection for cervical cancer screening among survivors of sexual trauma: a qualitative study.BMC Womens Health. 2024 Sep 13;24(1):509. doi: 10.1186/s12905-024-03301-x. BMC Womens Health. 2024. PMID: 39272185 Free PMC article.
-
At-home specimen self-collection as an additional testing strategy for chlamydia and gonorrhoea: a systematic literature review and meta-analysis.BMJ Glob Health. 2024 Aug 27;9(8):e015349. doi: 10.1136/bmjgh-2024-015349. BMJ Glob Health. 2024. PMID: 39191483 Free PMC article.
-
Accuracy of self-collected versus healthcare worker collected specimens for diagnosing sexually transmitted infections in females: an updated systematic review and meta-analysis.Sci Rep. 2024 May 7;14(1):10496. doi: 10.1038/s41598-024-61358-y. Sci Rep. 2024. PMID: 38714714 Free PMC article.
-
Cervical cancer screening pathways in France in 2015-2021, a nationwide study based on medico-administrative data.Prev Med Rep. 2023 Sep 28;36:102429. doi: 10.1016/j.pmedr.2023.102429. eCollection 2023 Dec. Prev Med Rep. 2023. PMID: 37810269 Free PMC article.
-
Concordance of Primary Human Papillomavirus Testing Among Clinicians and Patients: A Systematic Review.J Womens Health (Larchmt). 2023 Oct;32(10):1062-1072. doi: 10.1089/jwh.2023.0125. Epub 2023 Aug 16. J Womens Health (Larchmt). 2023. PMID: 37582276 Free PMC article.
References
-
- Noone A, Howlander N, Krapcho M, Miller D, Breast A, Yu M, et al. SEER Cancer Statistics Review, 1975–2015 [Internet]. National Cancer Institute. Bethesda, MD 2018. Available from: https://seer.cancer.gov/cr/1975_2015/
-
- Gamble S, Mawokomatanda T, Xu F, Chowdhury P, Pierannunzi C, Flegel D, et al. Surveillance for Certain Health Behaviors and Conditions Among States and Selected Local Areas — Behavioral Risk Factor Surveillance System, United States, 2013. and 2014. Vol. 66, MMWR Surveillance Summaries. 2017. - PMC - PubMed
-
- Moyer VA. Screening for cervical cancer: US Preventive Services Task Force recommendation statement. Ann Intern Med. 2012;156(12):880–91. - PubMed
-
- Smith JS, Lindsay L, Hoots B, Keys J, Franceschi S, Winer R, et al. Human papillomavirus type distribution in invasive cervical cancer and high‐grade cervical lesions: a meta‐analysis update. Int J cancer. 2007;121(3):621–32. - PubMed
